Pivotal Therapeutics Inc. announced financial results for the six months ended June 30, 2015. For the six months ended June 30, 2015 the company reported an increase in sales of 112% to CAD 268,176 compared to CAD 126,323 a year ago. The company reported a decrease of 30% in net loss to CAD 2,646,253 from CAD 3,786,445 a year ago.